Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VipaAlim is a traditional medicine and consumer health supplement developed and manufactured by Royal Medicalink Pharmalab in Indonesia. It is primarily formulated from the extract of *Channa striata* (snakehead fish), which is a potent natural source of albumin, essential amino acids, and minerals. The supplement is designed to support general health, enhance immune function, and assist in the recovery process by promoting tissue regeneration and maintaining plasma protein levels. It is particularly used for nutritional support in patients with hypoalbuminemia or those recovering from surgery and wounds. VipaAlim is produced under Indonesian Good Manufacturing Practices for Traditional Medicine (CPOTB) and is Halal certified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on VipaAlim.